πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 61 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8183207

Treatment of osteolytic disorders and cancer using CSF1R extracellular domain fusion molec

Five Prime Therapeutics, Inc. Β· Granted Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8105609

Flavivirus immunogens comprising extracellular viral particles composed of the premembrane

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8080246

Colony stimulating factor 1 receptor (CSF1R) extracellular domain fusion molecules

Five Prime Therapeutics, Inc. Β· Granted Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8080554

Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7723472

Extracellular matrix binding chimeric proteins and methods of use thereof

The Regents of the University of California Β· Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7300660

Abundant extracellular products and methods for their production and use

The Regents of the University of California Β· Granted Tue Nov 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7002002

Abundant extracellular products and methods for their production and use

The Regents of the University of California Β· Granted Tue Feb 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6818223

Abundant extracellular products and methods for their production and use

The Regents of the University of California Β· Granted Tue Nov 16 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6761894

Abundant extracellular products and methods for their production and use

The Regents of the University of California Β· Granted Tue Jul 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6752993

Abundant extracellular product vaccines and methods for their production and use

The Regents of the University of California Β· Granted Tue Jun 22 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6737511

Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 18 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6599510

Abundant extracellular products and methods for their production and use

The Regents of the University of California Β· Granted Tue Jul 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6150508

Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane

Northwest Biotherapeutics, Inc. Β· Granted Tue Nov 21 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired